anti-drd2 rabbit polyclonal antibody a12930 (ABclonal Biotechnology)
Structured Review

Anti Drd2 Rabbit Polyclonal Antibody A12930, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+drd2+polyclonal/anti+drd2+rabbit+pab+a12930/pmc09585581-252-21-25
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Developing Photoaffinity Probes for Dopamine Receptor D 2 to Determine Targets of Parkinson’s Disease Drugs"
Article Title: Developing Photoaffinity Probes for Dopamine Receptor D 2 to Determine Targets of Parkinson’s Disease Drugs
Journal: ACS Chemical Neuroscience
doi: 10.1021/acschemneuro.2c00544
Figure Legend Snippet: Intracellular calcium flux assay. HEK293T cell line stably expressing constructs for human DRD2 and a chimeric G-protein is loaded with calcium-sensing dye, Fura-4. After dosing the probe, confocal microscopy is used to determine the calcium flux in the cell by change in dye fluorescence. EC 50 curves determined with GraphPad software using a Hill slope of 1.0.
Techniques Used: Calcium Flux Assay, Stable Transfection, Expressing, Construct, Confocal Microscopy, Fluorescence, Software
Figure Legend Snippet: β-Arrestin recruitment analysis. (a) PRESTO-TANGO assay schematic: a ligand binds a chimeric DRD2 receptor, which then recruits β-arrestin fused with a TEV protease. The protease cuts a site between the receptor and a fused transcription factor, which then transits to the nuclease to initiate transcription of a luciferase gene. The luciferase activity is subsequently quantified. (b) Agonism of β-arrestin recruitment is quantified in EC 50 curves via the detection of luciferase activity, using a Hill slope of 1.0.
Techniques Used: Luciferase, Activity Assay
Figure Legend Snippet: Photo-cross-linking of dye-clicked probe: confocal microscopy. (a) Schematic of the methodology used in the labeling process. Cells stably expressing DRD2 fused to an N-terminal Strep Tag II are treated with DRD2-targeting probes 5 or 7 at 5 μM, photo-cross-linked, and excess probe is washed out. An Alexa Fluor 555 azide is then clicked to the probe, washed out, and cells are treated with an anti-Strep-Tag II antibody and fluorescent secondary to visualize DRD2. Nuclei were stained with DAPI. (b) Confocal microscopy results of labeled cells. All probes show some degree of labeling. However, probes 5 and 7 show a notable increase in the labeling density. Images taken with 40× magnification, scale bar: 10 μm.
Techniques Used: Confocal Microscopy, Labeling, Stable Transfection, Expressing, Strep-tag, Staining
Figure Legend Snippet: Flow cytometry quantification of probe labeling. (a) Schematic of flow cytometry workflow. (b) DRD2-expressing 293T cells or untransduced 293T cells (negative control) are treated with a 100 nm probe, which is photo-cross-linked, and an Alexa Fluor 555 azide is then “clicked” onto the probe. The cells were then analyzed by flow cytometry. P values determined using two-way ANOVA in GraphPad; **** corresponds to P < 0.0001.
Techniques Used: Flow Cytometry, Labeling, Expressing, Negative Control
Figure Legend Snippet: Photo-cross-linking of probes 5 and 7 to DRD2 visualized with Western blot. Lanes 1–5 correspond to samples with probe 5 at 100 nm, lanes 6–10 correspond to samples treated with probe 7 at 100 nm, and lanes 11–14 correspond to samples treated with negative control probe 16 . Lanes: 1, 6, and 11 are the anti-DRD2 antibody channel, lanes 2, 3, 7, 8, and 12 are fluorescence of the Alexa Fluor 555 clicked to the probes 5 , 7 , or 16 , lanes 4, 9, and 13 are the anti-Strep Tag antibody channel, and lanes 5, 10, and 14 are the overlaid channels for the respective probes.
Techniques Used: Western Blot, Negative Control, Fluorescence, Strep-tag
Related Articles
Blocking Assay:Article Title: Developing Photoaffinity Probes for Dopamine Receptor D 2 to Determine Targets of Parkinson’s Disease Drugs Article Snippet: Following blocking, the membrane was incubated with either 1 μg/mL Anti-Strep Tag II rabbit polyclonal antibody (Abcam, ab76949) or 2 μg/mL Article Title: Ankk1 Loss of Function Disrupts Dopaminergic Pathways in Zebrafish Article Snippet: Slides were subsequently incubated with Membrane:Article Title: Developing Photoaffinity Probes for Dopamine Receptor D 2 to Determine Targets of Parkinson’s Disease Drugs Article Snippet: Following blocking, the membrane was incubated with either 1 μg/mL Anti-Strep Tag II rabbit polyclonal antibody (Abcam, ab76949) or 2 μg/mL Article Title: Ankk1 Loss of Function Disrupts Dopaminergic Pathways in Zebrafish Article Snippet: Slides were subsequently incubated with Incubation:Article Title: Developing Photoaffinity Probes for Dopamine Receptor D 2 to Determine Targets of Parkinson’s Disease Drugs Article Snippet: Following blocking, the membrane was incubated with either 1 μg/mL Anti-Strep Tag II rabbit polyclonal antibody (Abcam, ab76949) or 2 μg/mL Article Title: Ankk1 Loss of Function Disrupts Dopaminergic Pathways in Zebrafish Article Snippet: Slides were subsequently incubated with Calcium Flux Assay:Article Title: Developing Photoaffinity Probes for Dopamine Receptor D 2 to Determine Targets of Parkinson’s Disease Drugs Article Snippet: Following blocking, the membrane was incubated with either 1 μg/mL Anti-Strep Tag II rabbit polyclonal antibody (Abcam, ab76949) or 2 μg/mL Article Title: Ankk1 Loss of Function Disrupts Dopaminergic Pathways in Zebrafish Article Snippet: Slides were subsequently incubated with Stable Transfection:Article Title: Developing Photoaffinity Probes for Dopamine Receptor D 2 to Determine Targets of Parkinson’s Disease Drugs Article Snippet: Following blocking, the membrane was incubated with either 1 μg/mL Anti-Strep Tag II rabbit polyclonal antibody (Abcam, ab76949) or 2 μg/mL Article Title: Ankk1 Loss of Function Disrupts Dopaminergic Pathways in Zebrafish Article Snippet: Slides were subsequently incubated with Expressing:Article Title: Developing Photoaffinity Probes for Dopamine Receptor D 2 to Determine Targets of Parkinson’s Disease Drugs Article Snippet: Following blocking, the membrane was incubated with either 1 μg/mL Anti-Strep Tag II rabbit polyclonal antibody (Abcam, ab76949) or 2 μg/mL Article Title: Ankk1 Loss of Function Disrupts Dopaminergic Pathways in Zebrafish Article Snippet: Slides were subsequently incubated with Construct:Article Title: Developing Photoaffinity Probes for Dopamine Receptor D 2 to Determine Targets of Parkinson’s Disease Drugs Article Snippet: Following blocking, the membrane was incubated with either 1 μg/mL Anti-Strep Tag II rabbit polyclonal antibody (Abcam, ab76949) or 2 μg/mL Article Title: Ankk1 Loss of Function Disrupts Dopaminergic Pathways in Zebrafish Article Snippet: Slides were subsequently incubated with Confocal Microscopy:Article Title: Developing Photoaffinity Probes for Dopamine Receptor D 2 to Determine Targets of Parkinson’s Disease Drugs Article Snippet: Following blocking, the membrane was incubated with either 1 μg/mL Anti-Strep Tag II rabbit polyclonal antibody (Abcam, ab76949) or 2 μg/mL Article Title: Ankk1 Loss of Function Disrupts Dopaminergic Pathways in Zebrafish Article Snippet: Slides were subsequently incubated with Fluorescence:Article Title: Developing Photoaffinity Probes for Dopamine Receptor D 2 to Determine Targets of Parkinson’s Disease Drugs Article Snippet: Following blocking, the membrane was incubated with either 1 μg/mL Anti-Strep Tag II rabbit polyclonal antibody (Abcam, ab76949) or 2 μg/mL Article Title: Ankk1 Loss of Function Disrupts Dopaminergic Pathways in Zebrafish Article Snippet: Slides were subsequently incubated with Software:Article Title: Developing Photoaffinity Probes for Dopamine Receptor D 2 to Determine Targets of Parkinson’s Disease Drugs Article Snippet: Following blocking, the membrane was incubated with either 1 μg/mL Anti-Strep Tag II rabbit polyclonal antibody (Abcam, ab76949) or 2 μg/mL Article Title: Ankk1 Loss of Function Disrupts Dopaminergic Pathways in Zebrafish Article Snippet: Slides were subsequently incubated with Luciferase:Article Title: Developing Photoaffinity Probes for Dopamine Receptor D 2 to Determine Targets of Parkinson’s Disease Drugs Article Snippet: Following blocking, the membrane was incubated with either 1 μg/mL Anti-Strep Tag II rabbit polyclonal antibody (Abcam, ab76949) or 2 μg/mL Article Title: Ankk1 Loss of Function Disrupts Dopaminergic Pathways in Zebrafish Article Snippet: Slides were subsequently incubated with Activity Assay:Article Title: Developing Photoaffinity Probes for Dopamine Receptor D 2 to Determine Targets of Parkinson’s Disease Drugs Article Snippet: Following blocking, the membrane was incubated with either 1 μg/mL Anti-Strep Tag II rabbit polyclonal antibody (Abcam, ab76949) or 2 μg/mL Article Title: Ankk1 Loss of Function Disrupts Dopaminergic Pathways in Zebrafish Article Snippet: Slides were subsequently incubated with Labeling:Article Title: Developing Photoaffinity Probes for Dopamine Receptor D 2 to Determine Targets of Parkinson’s Disease Drugs Article Snippet: Following blocking, the membrane was incubated with either 1 μg/mL Anti-Strep Tag II rabbit polyclonal antibody (Abcam, ab76949) or 2 μg/mL Article Title: Ankk1 Loss of Function Disrupts Dopaminergic Pathways in Zebrafish Article Snippet: Slides were subsequently incubated with Strep-tag:Article Title: Developing Photoaffinity Probes for Dopamine Receptor D 2 to Determine Targets of Parkinson’s Disease Drugs Article Snippet: Following blocking, the membrane was incubated with either 1 μg/mL Anti-Strep Tag II rabbit polyclonal antibody (Abcam, ab76949) or 2 μg/mL Article Title: Ankk1 Loss of Function Disrupts Dopaminergic Pathways in Zebrafish Article Snippet: Slides were subsequently incubated with Staining:Article Title: Developing Photoaffinity Probes for Dopamine Receptor D 2 to Determine Targets of Parkinson’s Disease Drugs Article Snippet: Following blocking, the membrane was incubated with either 1 μg/mL Anti-Strep Tag II rabbit polyclonal antibody (Abcam, ab76949) or 2 μg/mL Article Title: Ankk1 Loss of Function Disrupts Dopaminergic Pathways in Zebrafish Article Snippet: Slides were subsequently incubated with Flow Cytometry:Article Title: Developing Photoaffinity Probes for Dopamine Receptor D 2 to Determine Targets of Parkinson’s Disease Drugs Article Snippet: Following blocking, the membrane was incubated with either 1 μg/mL Anti-Strep Tag II rabbit polyclonal antibody (Abcam, ab76949) or 2 μg/mL Article Title: Ankk1 Loss of Function Disrupts Dopaminergic Pathways in Zebrafish Article Snippet: Slides were subsequently incubated with Negative Control:Article Title: Developing Photoaffinity Probes for Dopamine Receptor D 2 to Determine Targets of Parkinson’s Disease Drugs Article Snippet: Following blocking, the membrane was incubated with either 1 μg/mL Anti-Strep Tag II rabbit polyclonal antibody (Abcam, ab76949) or 2 μg/mL Article Title: Ankk1 Loss of Function Disrupts Dopaminergic Pathways in Zebrafish Article Snippet: Slides were subsequently incubated with Western Blot:Article Title: Developing Photoaffinity Probes for Dopamine Receptor D 2 to Determine Targets of Parkinson’s Disease Drugs Article Snippet: Following blocking, the membrane was incubated with either 1 μg/mL Anti-Strep Tag II rabbit polyclonal antibody (Abcam, ab76949) or 2 μg/mL Article Title: Ankk1 Loss of Function Disrupts Dopaminergic Pathways in Zebrafish Article Snippet: Slides were subsequently incubated with Immunohistochemistry:Article Title: Developing Photoaffinity Probes for Dopamine Receptor D 2 to Determine Targets of Parkinson’s Disease Drugs Article Snippet: Following blocking, the membrane was incubated with either 1 μg/mL Anti-Strep Tag II rabbit polyclonal antibody (Abcam, ab76949) or 2 μg/mL Article Title: Ankk1 Loss of Function Disrupts Dopaminergic Pathways in Zebrafish Article Snippet: Slides were subsequently incubated with |


